Healthcare's defensive demand is strengthening in 2026. BTSG, HRMY, UNH and NVCR stand out on improv

Stocks like SNX, AMP, HRMY and NWL are seeing price strength and have a high chance of carrying the

PLYMOUTH MEETING, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq:

Harmony Biosciences (NASDAQ: HRMY) reported second-quarter net revenue of $261.3 million, up 30% fro

Harmony Biosciences Holdings, Inc. has now elevated BP-205, its orexin-2 receptor agonist, to lead t

HRMY tops Q2 estimates as Wakix demand fuels 30% revenue growth. A growing pipeline, BP-205 progress

Harmony Biosciences (HRMY) could produce exceptional returns because of its solid growth attributes.

Harmony Biosciences Holdings, Inc. (HRMY) Q2 2026 Earnings Call Transcript

Harmony Biosciences NASDAQ: HRMY reported second-quarter net revenue of $261.3 million, up 30% from

Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $1.28 per share, beati

WAKIX® Net Revenue Grew 30% Year over Year to $261.3 Million for Second Quarter 2026; Estimated Aver

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Harmony Biosciences Hldgs (NASDAQ:

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced preliminary, unaudited second quart

Harmony Biosciences Hldgs (NASDAQ:HRMY) affirms prelim FY2026 sales outlook from $1.000 billion-$1.0

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings

Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for it